PL
Polianta Ltd Portfolio holdings
AUM
$232M
1-Year Return
11.24%
This Quarter Return
+10%
1 Year Return
+11.24%
3 Year Return
+30.36%
5 Year Return
+48.65%
10 Year Return
–
AUM
$169M
AUM Growth
+$14.6M
(+9.5%)
Cap. Flow
+$8.48M
Cap. Flow
% of AUM
5.02%
Top 10 Holdings %
Top 10 Hldgs %
63.62%
Holding
112
New
48
Increased
9
Reduced
3
Closed
50
Top Buys
| 1 |
iShares S&P 500 Growth ETF
IVW
|
$12.3M |
| 2 |
iShares S&P Small-Cap 600 Growth ETF
IJT
|
$12.2M |
| 3 |
Vanguard S&P Small-Cap 600 ETF
VIOO
|
$12.2M |
| 4 |
Materials Select Sector SPDR Fund
XLB
|
$12.1M |
| 5 |
Tandem Diabetes Care
TNDM
|
$1.29M |
Top Sells
| 1 |
Vanguard Growth ETF
VUG
|
$11.8M |
| 2 |
Schwab US Large-Cap Growth ETF
SCHG
|
$11.7M |
| 3 |
Vanguard Large-Cap ETF
VV
|
$11.3M |
| 4 |
Vanguard Materials ETF
VAW
|
$11M |
| 5 |
MongoDB
MDB
|
$1.15M |
Sector Composition
| 1 | Technology | 7.22% |
| 2 | Consumer Discretionary | 7.12% |
| 3 | Healthcare | 6.19% |
| 4 | Industrials | 5.61% |
| 5 | Financials | 4.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Neurocrine Biosciences
NBIX
$13.9B
| $1.14M | 0.68% |
+11,900
| New | +$1.14M |
|
52
Reinsurance Group of America
RGA
$13.1B
| $1.14M | 0.68% |
+12,000
| New | +$1.14M |
|
53
MetLife
MET
$54.4B
| $1.14M | 0.68% |
+30,700
| New | +$1.14M |
|
54
WEX
WEX
$5.94B
| $1.14M | 0.67% |
+8,200
| New | +$1.14M |
|
55
Newmont
NEM
$82.3B
| $1.14M | 0.67% |
+17,900
| New | +$1.14M |
|
|
BLUE
56
DELISTED
bluebird bio
BLUE
| $1.13M | 0.67% |
+1,613
| New | +$1.13M |
|
57
FibroGen
FGEN
$45.7M
| $1.13M | 0.67% |
+1,096
| New | +$1.13M |
|
58
Southwest Airlines
LUV
$16.3B
| $1.13M | 0.67% |
+30,000
| New | +$1.13M |
|
59
United Therapeutics
UTHR
$17.2B
| $1.08M | 0.64% |
+10,700
| New | +$1.08M |
|
60
Valvoline
VVV
$4.95B
| $1.07M | 0.63% |
56,400
+5,200
| +10% | +$98.9K |
|
61
Medpace
MEDP
$13.6B
| $1.06M | 0.63% |
+9,500
| New | +$1.06M |
|
62
NOV
NOV
$4.96B
| $1.03M | 0.61% |
113,300
+27,700
| +32% | +$251K |
|
63
AbbVie
ABBV
$376B
| – | – |
-10,900
| Closed | -$1.07M |
|
64
Alaska Air
ALK
$7.24B
| – | – |
-27,600
| Closed | -$1M |
|
65
Allstate
ALL
$54.9B
| – | – |
-10,200
| Closed | -$989K |
|
|
AMED
66
DELISTED
Amedisys
AMED
| – | – |
-5,600
| Closed | -$1.11M |
|
67
APA Corp
APA
$8.39B
| – | – |
-66,300
| Closed | -$895K |
|
68
Becton Dickinson
BDX
$54.8B
| – | – |
-4,203
| Closed | -$981K |
|
69
Biogen
BIIB
$20.5B
| – | – |
-3,800
| Closed | -$1.02M |
|
70
Booking.com
BKNG
$181B
| – | – |
-600
| Closed | -$955K |
|
71
Burlington
BURL
$19B
| – | – |
-4,700
| Closed | -$925K |
|
72
Cogent Communications
CCOI
$1.8B
| – | – |
-12,800
| Closed | -$990K |
|
73
Church & Dwight Co
CHD
$23.2B
| – | – |
-12,900
| Closed | -$997K |
|
74
Chewy
CHWY
$17B
| – | – |
-21,300
| Closed | -$951K |
|
75
Carlisle Companies
CSL
$16.8B
| – | – |
-8,400
| Closed | -$1.01M |
|